ArticleIndian journal of ophthalmology2026
Three-month outcomes of PresbyEDOF: A retrospective case study evaluating a laser-based corneal solution for presbyopia correction.
Article in Indian journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the safety, efficacy, and refractive predictability of PresbyEDOF, an individualized corneal laser technique for presbyopia correction.
methodsIn this retrospective, single-center case series, 114 eyes of 57 patients (mean age 54 ± 4.7 years) were treated with PresbyEDOF using the SCHWIND AMARIS 1050RS. The treatment induced approximately 1.5 D of extended depth of focus in both the near-dominant and far-dominant eye, with a planned anisometropia of 1.5 D. Primary outcomes at 3 months included binocular uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), refractive predictability, change in corrected distance visual acuity (CDVA), residual astigmatism, retreatment rate, and visual disturbances.
resultsBinocular UDVA of 0.0 logMAR was achieved in 92% of patients. UNVA of ≥0.0 logMAR was achieved in 40% and ≥0.2 logMAR in 93% of patients. CDVA remained unchanged in 38% of eyes, decreased by one line in 27%, and improved by one line in 35%. Residual astigmatism >0.5 D occurred in 4% of eyes. Retreatment was required in three patients (5.3%), including two cases retargeted for improved intermediate vision. No intraoperative complications, ectasia, or infections were observed. All patients reported improved visual quality, with photic phenomena described as rare and transient.
conclusionsPresbyEDOF demonstrated favorable distance and near visual outcomes, high visual quality, and low residual astigmatism at 3 months. The technique appears to be a safe and effective corneal approach for presbyopia correction, warranting further prospective studies with longer follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.